The companys shares soaredover 30% during Mondaytrading following the news.
An Eli Lilly executive told Quartz that it will take aGLP-1 pillto address current supply constraints.
However, the agency does not review the safety and efficacy of these products.
The company is offering compounded semaglutide for $199 a month.Image: Hims & Hers
In December, Hims & Herslaunched a weight loss program that included access to non-GLP-1 weight loss medications.
The companys other weight loss medication offerings focus on treating the underlying causes of weight gain.
This article originally appeared onQuartz.
News from the future, delivered to your present.